Neurotransmitters

Product #

Image

Description

Biochem/physiol Actions

Add to Cart

219096 D-Aspartic acid ReagentPlus®, 99%  
G1001 D-Glutamic acid ≥99% (TLC) Unnatural isomer of glutamic acid.
A9506 L-Aspartic acid hemimagnesium salt hydrate ≥98% (TLC) Principal neurotransmitter for fast synaptic excitation.
A6558 L-Aspartic acid potassium salt ≥98% (HPLC) Principal neurotransmitter for fast synaptic excitation.
A6683 L-Aspartic acid sodium salt monohydrate ≥98% (TLC) Principal neurotransmitter for fast synaptic excitation.
A9256 L-Aspartic acid reagent grade, ≥98% (HPLC) Principal neurotransmitter for fast synaptic excitation.
309346 L-Glutamic acid diethyl ester hydrochloride 97%  
G2128 L-Glutamic acid hydrochloride ≥99% (HPLC) Agonist at kainate, NMDA, and quisqualate receptors; an excitatory amino acid neurotransmitter.
L-glutamate plays key roles in development, learning, memory, plasticity and cognition. It plays crucial role in the pathogenesis of neuropathological diseases such as epilepsy, schizophrenia, stroke, ischemia, ALS (amyotrophic lateral sclerosis), Huntington’s disease and Parkinson’s disease. Glutamate is also responsible for the activation of long-term potentiation (LTP) and long-term depression (LTD). Induction of glutamate receptors plays a key role in the pathophysiology of migraine.
G1626 L-Glutamic acid monosodium salt hydrate ≥99% (HPLC), powder Agonist at kainate, NMDA, and quisqualate receptors; an excitatory amino acid neurotransmitter.
L-glutamate plays key roles in development, learning, memory, plasticity and cognition. It plays crucial role in the pathogenesis of neuropathological diseases such as epilepsy, schizophrenia, stroke, ischemia, ALS (amyotrophic lateral sclerosis), Huntington’s disease and Parkinson’s disease. Glutamate is also responsible for the activation of long-term potentiation (LTP) and long-term depression (LTD). Induction of glutamate receptors plays a key role in the pathophysiology of migraine.
G1501 L-Glutamic acid potassium salt monohydrate ≥99% (HPLC), powder Agonist at kainate, NMDA, and quisqualate receptors; an excitatory amino acid neurotransmitter.
L-glutamate plays key roles in development, learning, memory, plasticity and cognition. It plays crucial role in the pathogenesis of neuropathological diseases such as epilepsy, schizophrenia, stroke, ischemia, ALS (amyotrophic lateral sclerosis), Huntington’s disease and Parkinson’s disease. Glutamate is also responsible for the activation of long-term potentiation (LTP) and long-term depression (LTD). Induction of glutamate receptors plays a key role in the pathophysiology of migraine.
G1251 L-Glutamic acid ReagentPlus®, ≥99% (HPLC) An excitatory amino acid neurotransmitter that is an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA).
G3291 Glutamate, Caged hydrate powder Glutamate derivative that is resistant to hydrolysis and biologically inert prior to photolysis.
L1045   LY-354740 hydrate ≥98% (HPLC) LY-354740 is a highly selective and potent agonist of group II mGlu (metabotropic glutamate) receptors. It displays antianxiety and antiaddictive activity in vivo. It?s orally and systemically active. It is anxiolytic and inhibits symptoms of morphine withdrawal in morphine-dependent mice.
A5930 N-Acetyl-Asp-Glu ≥97% (TLC), powder Endogenous neurotransmitter localized to neurons with high affinity for metabotropic glutamate receptors, mGluR3. It is an antagonist at NMDA receptors. Catabolized by carboxypeptidase II, which is expressed on astrocyte membranes, to N-acetylaspartate and glutamate.